India Drug Manufacturers Stock News
Categories
- All
- Editor's Picks
- Stock Market News
- Q&A with Gurus
- Gurus' Stock Picks
- Insider Transaction
- Earning Reports
- CEO Shareholder Letters
- Press Release
- Earnings Call Transcripts
- Podcast
Industries
- Aerospace & Defense
- Agriculture
- Asset Management
- Banks
- Beverages - Alcoholic
- Beverages - Non-Alcoholic
- Biotechnology
- Building Materials
- Business Services
- Capital Markets
- Chemicals
- Conglomerates
- Construction
- Consumer Packaged Goods
- Credit Services
- Diversified Financial Services
- Drug Manufacturers
- Education
- Farm & Heavy Construction Machinery
- Forest Products
- Furnishings, Fixtures & Appliances
- Hardware
- Healthcare Plans
- Healthcare Providers & Services
- Homebuilding & Construction
- Industrial Distribution
- Industrial Products
- Insurance
- Interactive Media
- Manufacturing - Apparel & Accessories
- Media - Diversified
- Medical Devices & Instruments
- Medical Diagnostics & Research
- Medical Distribution
- Metals & Mining
- Oil & Gas
- Other Energy Sources
- Packaging & Containers
- Personal Services
- Real Estate
- REITs
- Restaurants
- Retail - Cyclical
- Retail - Defensive
- Semiconductors
- Software
- Steel
- Telecommunication Services
- Tobacco Products
- Transportation
- Travel & Leisure
- Utilities - Independent Power Producers
- Utilities - Regulated
- Vehicles & Parts
- Waste Management
GuruFocus Research Drug Manufacturers
Glenmark Pharmaceuticals Ltd (BOM:532296) Q1 2025 Earnings Call Transcript Highlights: Strong Growth in Europe and India Amid US Challenges
Glenmark Pharmaceuticals Ltd (BOM:532296) reports robust revenue growth and strategic advancements despite hurdles in the US market. Aug 19, 2024
GuruFocus Research Drug Manufacturers
Natco Pharma Ltd (BOM:524816) Q1 2025 Earnings Call Transcript Highlights: Strong Revenue and Profit Growth Driven by Export Formulations
Natco Pharma Ltd (BOM:524816) reports a 21.6% increase in total revenue and a 59% rise in net profit for Q1 FY25. Aug 15, 2024
GuruFocus Research Drug Manufacturers
Aurobindo Pharma Ltd (BOM:524804) Q1 2025 Earnings Call Transcript Highlights: Strong Revenue Growth and Profit Surge Amid Operational Challenges
Aurobindo Pharma Ltd (BOM:524804) reports a 10% revenue growth and a 61% increase in net profit for Q1 FY25, despite facing higher operating expenses and remediation costs. Aug 13, 2024
GuruFocus Research Drug Manufacturers
Alkem Laboratories Ltd (BOM:539523) Q1 2025 Earnings Call Transcript Highlights: Strong EBITDA Margin and Regulatory Compliance
Alkem Laboratories Ltd (BOM:539523) reports significant improvements in profitability and successful resolution of regulatory issues. Aug 12, 2024
GuruFocus Research Drug Manufacturers
Gland Pharma Ltd (NSE:GLAND) Q1 2025 Earnings Call Transcript Highlights: Strong Revenue Growth Amid Margin Pressures
Gland Pharma Ltd (NSE:GLAND) reports a 16% year-on-year revenue growth, but faces challenges with declining EBITDA margins and net profit. Aug 10, 2024